| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/11/2004 | US20040047870 For therapy of atherosclerosis, cardiovascular disease, cerebrovascular disease, peripheral vascular disease, stenosis, restenosis and/or in-stent-stenosis |
| 03/11/2004 | US20040047869 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 03/11/2004 | US20040047868 Administering probiotic, wherein the probiotic is probiotic bacteria selected from Lactobacillus species, with the proviso that the Lactobacillus species is not Lactobacillus GG for prophylaxis and therapy of endotoxemia |
| 03/11/2004 | US20040047850 Bifidobacteria and preparations containing them |
| 03/11/2004 | US20040047848 Induction of immunological tolerance |
| 03/11/2004 | US20040047847 Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from a Pol III promoter |
| 03/11/2004 | US20040047811 Aerodynamically light particles for pulmonary drug delivery |
| 03/11/2004 | US20040047810 Microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the |
| 03/11/2004 | US20040047809 An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter of |
| 03/11/2004 | US20040047807 Neurotoxic substances, which have a toxic effect in particular for the axon and the nociceptive nerve endings, for the preparation of an agent for the treatment of joint pain. |
| 03/11/2004 | US20040046305 Method and device for inserting a plurality of individual sheetlike forms of administration in a dispenser by forming a multilayer pile |
| 03/11/2004 | US20040045805 Novel process for preparing and harvesting crystalline particles |
| 03/11/2004 | US20040045548 Two-chamber cartridge for propellant-free metering aerosols |
| 03/11/2004 | US20040045546 Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use |
| 03/11/2004 | DE10334820A1 Pharmazeutische Zusammensetzungen mit antibiotischer Aktivität Pharmaceutical compositions having antibiotic activity |
| 03/11/2004 | DE10219784A1 Orally administered solution used for rehydration, especially in diarrhea patients, is enclosed in taste masking carrier of absorbable polymer, specifically in form of microcapsules |
| 03/11/2004 | CA2706622A1 Lps activation of phagocytic activity |
| 03/11/2004 | CA2502734A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 03/11/2004 | CA2497165A1 Improved bacterial outer membrane vesicles |
| 03/11/2004 | CA2497142A1 Microencapsulated materials and method of making same |
| 03/11/2004 | CA2497136A1 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 03/11/2004 | CA2497121A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
| 03/11/2004 | CA2497116A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
| 03/11/2004 | CA2497114A1 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 03/11/2004 | CA2497112A1 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 03/11/2004 | CA2496806A1 Oral liquid tolterodine composition |
| 03/11/2004 | CA2496798A1 Embossable and writable multilaminate backing construction |
| 03/11/2004 | CA2496796A1 Medicinal product packaging |
| 03/11/2004 | CA2496769A1 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 03/11/2004 | CA2496612A1 Embolization |
| 03/11/2004 | CA2496447A1 Amelioration of effects of cigarette smoke |
| 03/11/2004 | CA2496314A1 Methods of treating idiopathic pulmonary fibrosis |
| 03/11/2004 | CA2495800A1 Breath freshening and oral cleansing product using geraniol |
| 03/11/2004 | CA2495793A1 Breath freshening and oral cleansing product using cardamom oil |
| 03/11/2004 | CA2495144A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 03/11/2004 | CA2495069A1 Breath freshening and oral cleansing product using citral |
| 03/11/2004 | CA2495064A1 Breath freshening and oral cleansing product using salicylaldehyde |
| 03/10/2004 | EP1396266A1 Aqueous cilostazol preparation for injection |
| 03/10/2004 | EP1396263A1 Film coating for tablets and caplets |
| 03/10/2004 | EP1395626A1 Peg-poe, peg-poe-peg, and poe-peg-poe block copolymers |
| 03/10/2004 | EP1395607A2 Respiratory syncytial virus |
| 03/10/2004 | EP1395604A1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 03/10/2004 | EP1395419A1 Preservation of biological materials using fiber-forming techniques |
| 03/10/2004 | EP1395334A1 Device for applying substances |
| 03/10/2004 | EP1395305A1 Using supercritical fluids to infuse therapeutic on a medical device |
| 03/10/2004 | EP1395294A2 Pulmonary administration of chemically modified insulin |
| 03/10/2004 | EP1395278A2 Ocular tear growth factor-like protein |
| 03/10/2004 | EP1395270A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatit |
| 03/10/2004 | EP1395268A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 03/10/2004 | EP1395260A1 Use of the opioid antagonist naltrexone to prevent and control side effects caused by opioids |
| 03/10/2004 | EP1395258A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
| 03/10/2004 | EP1395254A1 Oral pharmaceutical composition containing a statin derivative |
| 03/10/2004 | EP1395252A1 Medicaments for treating colics |
| 03/10/2004 | EP1395250A1 Surface-doped plaster containing an active ingredient |
| 03/10/2004 | EP1395249A1 Soft elastic capsules comprising ritonavir and/or lopinavir |
| 03/10/2004 | EP1395248A1 Fluid delivery device and associated method |
| 03/10/2004 | EP1395247A2 Oxcarbazepine dosage forms |
| 03/10/2004 | EP1395246A1 Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protection |
| 03/10/2004 | EP1395245A1 Foamed sol-gel and method of manufacturing the same |
| 03/10/2004 | EP1395243A2 Encapsulation of nanosuspensions in liposomes and microspheres |
| 03/10/2004 | EP1395242A1 Liquid pharmaceutical composition |
| 03/10/2004 | EP1395241A1 Implantable medical device with controllable gaseous agent release system |
| 03/10/2004 | EP1395240A1 Modification of the sustained release profile |
| 03/10/2004 | EP1395223A2 Pharmaceutical dispensing apparatus and method |
| 03/10/2004 | EP1395215A1 Quinolone carboxylic acid compositions and related methods of treatment |
| 03/10/2004 | EP1395214A1 Prevention of myocardial infarction induced ventricular expansion and remodeling |
| 03/10/2004 | EP1303249B1 Antimycotic nail varnish composition |
| 03/10/2004 | EP1231911B1 Directly compressible, ultra fine acetaminophen compositions and process for producing same |
| 03/10/2004 | EP1216091B1 Method for encapsulating active substances by coacervation of polymers in non-chlorinated organic solvent |
| 03/10/2004 | EP1180062B1 Method for producing morphologically uniform micro and nanoparticles using micromixers |
| 03/10/2004 | EP1124816B1 Products for body hygiene based on lapacho extracts containing quercitine, their preparation and use |
| 03/10/2004 | EP1100499B1 Use of eletriptan for the prevention of migraine recurrence |
| 03/10/2004 | EP1094788B1 Croscarmellose taste masking |
| 03/10/2004 | EP1030660B1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof |
| 03/10/2004 | EP0980245B1 Use of misoprostol or/and misoprostol acid for the treatment of erectile dysfunction |
| 03/10/2004 | EP0938342B1 Injectable combination of polymers for the manufacture of an in situ implant |
| 03/10/2004 | EP0854729B1 Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
| 03/10/2004 | EP0854718B1 Novel composition containing an acid-labile benzimidazole and process for its preparation |
| 03/10/2004 | EP0820300B1 Controlled release biodegradable nanoparticles containing insulin |
| 03/10/2004 | EP0792147B1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs |
| 03/10/2004 | EP0767634B1 Microcapsules for administration of neuroactive agents |
| 03/10/2004 | CN1481259A Process to improve stability of pharmaceutical compsn |
| 03/10/2004 | CN1481257A Compsn and its method |
| 03/10/2004 | CN1481254A Adjuvant compsn comprising immunostimulatory oligonucleotide and tocol |
| 03/10/2004 | CN1481253A Drugs and foods improving quality of life and process for producng same |
| 03/10/2004 | CN1481252A Stabilized Inteferon compsns |
| 03/10/2004 | CN1481250A Improved and stable extract from hypericum perforatuml, method for prodn thereof |
| 03/10/2004 | CN1481247A Use of zolendronate for mfg. medicament for treatment of bone metabolism diseases |
| 03/10/2004 | CN1481241A Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 03/10/2004 | CN1481237A Method for producing organic solvent-free lycopene concentrate, resulting concentrate and compsn comprising said concentrate |
| 03/10/2004 | CN1481236A Aerogel powder comprising therapeutic agents |
| 03/10/2004 | CN1481235A Microgranules based on active principle and method for making same |
| 03/10/2004 | CN1480528A Bifidobacterium and products contg same |
| 03/10/2004 | CN1480496A Polyacrylic acid film forming compsn. |
| 03/10/2004 | CN1480226A Antibiotic coating of porous body, its prepn. and application |
| 03/10/2004 | CN1480218A Medicinal preparation of slowly-released bioactive substance, its prepn. and application |
| 03/10/2004 | CN1480217A Medicinal preparation and its prepn. and application |
| 03/10/2004 | CN1480216A Compound antimicrobial for treating wound of body surface and its preparing method |
| 03/10/2004 | CN1480212A Application of neurotoxin therapy in treatment of urinary system and relative diseases |
| 03/10/2004 | CN1480204A Preparation of Chinese herbal medicine for treating barrenness of women |